• 循环辅助支持治疗在心原性休克中的应用研究
  • Efficacy of circulatory support in patients with cardiogenic shock
  • 姜璐.循环辅助支持治疗在心原性休克中的应用研究[J].内科急危重症杂志,2017,23(6):459-461
    扫码阅读全文 本文二维码信息
    DOI:10.11768/nkjwzzzz20170605
    中文关键词:  心原性休克  主动脉内球囊反搏术  体外膜肺氧合
    英文关键词:
    基金项目:
    作者单位E-mail
    姜璐 华中科技大学同济医学院附属同济医院 jiangjg618@126.com 
    摘要点击次数: 1553
    全文下载次数: 2511
    中文摘要:
          目的:观察循环辅助支持治疗在心原性休克患者中的治疗效果。方法:回顾性分析57例心原性休克患者的临床资料,根据是否进行主动脉内球囊反搏术(IABP)和体外膜肺氧合(ECMO)辅助治疗将患者分为观察组(32例)和对照组(25例),比较2组患者的体检和实验室检查结果、心脏功能、住院病死率等相关指标。结果:观察组院内病死率明显低于对照组(P<0.05)。与治疗前比较,观察组治疗后的左室射血分数(LVEF)明显增高(P<0.05),而对照组差异无统计学意义(P>0.05)。2组患者治疗后的收缩压、舒张压均明显升高,心率均明显降低(P<0.05)。结论:循环辅助支持治疗可以改善心原性休克患者的心功能,降低院内病死率。
    英文摘要:
          Objective: To investigate the clinical effect of circulatory support in the treatment of cardiogenic shock. Methods: A total of 57 patients with cardiogenic shock were retrospectively investigated. All cases were divided into observation group (n=32) and control group (n=25) according to whether IABP and ECMO were given or not. The physical examination was performed, and laboratory test results, cardiac function, and the hospital mortality were observed. Results: The hospital mortality in the observation group was significantly lower than that in the control group. After treatment, the left ventricular ejection fraction in the observation group was higher than that before treatment (P<0.05), and there was no significant difference before and after treatment in the control group (P>0.05). The systolic blood and diastolic blood pressures were significantly increased and heart rate were significantly decreased in both groups after treatment (P<0.05). Conclusion: The circulatory support can improve cardiac function and reduce the hospital mortality in patients with cardiogenic shock.